Higher-riskArticle link

What's Happening: Understanding Severe Agitation and When Antipsychotics Are (and Aren't) the Answer

When someone with dementia becomes aggressive, hallucinates, or is intensely agitated, it is a damaged brain communicating distress—not 'bad behavior.' Antipsychotics can sometimes help, but they carry a boxed warning for increased death and stroke and are a true last resort reserved only for dangerous, psychosis-linked behaviors. This guide explains why these behaviors happen, the safer steps to try first, and exactly how to partner with a clinician if medication is ever considered.

Key points

  • Severe behaviors are a symptom of a damaged brain expressing distress, not willful misbehavior—look for the unmet need behind it.
  • Always rule out pain, infection, constipation, and delirium first; these are common, treatable causes.
  • NICE and AAFP guidelines require non-drug approaches as the foundation of care, continued even if medication is later added.
  • Antipsychotics are a last resort only for severe, dangerous behavior linked to psychosis—never for wandering, restlessness, or sleep.
  • These drugs carry serious risks: increased mortality, stroke, falls, heavy sedation, confusion, and movement disorders; evidence of benefit is modest and low-quality.
  • Safer medication alternatives to try first include acetaminophen for pain (ask the doctor), antidepressants (citalopram, sertraline), and dementia drugs (donepezil, rivastigmine, memantine).
  • If an antipsychotic is used: lowest effective dose, shortest possible time, close monitoring, and a planned gradual dose reduction after 2–8 months of stability.
  • In Lewy body or Parkinson's disease dementia, most antipsychotics are dangerous—only quetiapine or clozapine may be considered, under specialist supervision.

Understanding the situation

In dementia, the brain loses its ability to filter impulses and interpret the world correctly—imagine a volume knob stuck on high, where small triggers spark huge reactions. Because the person often cannot say what is wrong, distress comes out as yelling, hitting, pacing, paranoia, or resisting care. The most common hidden drivers are physical: pain, a urinary tract infection or other infection, constipation, hunger, thirst, a full bladder, overstimulation, or a sudden change in routine. Pain is especially common and easily missed. Antipsychotics (such as risperidone, olanzapine, quetiapine, and aripiprazole) work by blocking dopamine to reduce hallucinations, delusions, and aggression, but they raise the risk of death even in people with no heart problems, plus stroke, falls, heavy sedation, confusion, and stiffness or tremors. Major guidelines from NICE (National Institute for Health and Care Excellence) and the AAFP (American Academy of Family Physicians) are clear: non-drug strategies come first, and medication is only for severe, dangerous symptoms after other approaches have genuinely failed.

General caregiving information, not medical advice. Check medications and major care changes with your clinician.

Step-by-step

  1. Rule out physical causes first. Look for pain (grimacing, guarding a body part, new restlessness), infection (especially UTI), constipation, dehydration, hunger, thirst, or a full bladder. Ask the doctor whether a trial of scheduled acetaminophen at a safe dose is appropriate—pain relief alone sometimes dramatically reduces agitation.

  2. Check for delirium. If agitation came on suddenly over hours or a day, suspect infection, dehydration, or a medication side effect and call the doctor right away—this is treatable and different from baseline dementia behavior.

  3. Apply non-drug calming strategies consistently for at least 2 weeks (the minimum trial before any antipsychotic discussion): lower the lights, reduce noise and clutter, speak slowly in a gentle voice, offer a favorite snack, redirect to a pleasant activity, keep a steady daily routine, try familiar music or aromatherapy, and use reassuring touch. If the person gets more upset, stop and give space.

  4. Log every episode—time, suspected trigger, the behavior, what you tried, and the result. Patterns (for example, agitation right after bathing) often reveal the non-drug solution.

  5. Understand the indication: antipsychotics are appropriate only for dangerous behavior linked to psychosis (hallucinations, delusions, severe paranoia) or behavior that poses a danger to the person or others. They are NOT for wandering, sleep problems, or general restlessness.

  6. If non-drug strategies fail, ask the clinician about safer medication options first—cholinesterase inhibitors (donepezil, rivastigmine), memantine, or an antidepressant such as citalopram or sertraline if depression or anxiety contributes (these take 2–4 weeks to work).

  7. If an antipsychotic is still considered, schedule a visit with the primary care clinician or geriatric psychiatrist, bring your behavior log and full medication list, and confirm in writing: the target symptom, the lowest starting dose, the trial length, clear success criteria, a monitoring plan for sedation/falls/stiffness, and a scheduled review date. Never adjust the dose yourself.

  8. Plan the exit from day one. Agree to attempt a gradual dose reduction after 2–8 months of stability, and taper slowly under medical supervision—never stop abruptly.

What not to do

  • Do NOT use an antipsychotic as a first-line treatment—they carry a boxed warning for increased death and stroke in older adults with dementia.

  • Do NOT start an antipsychotic before trying non-drug strategies consistently for at least 2 weeks.

  • Do NOT give antipsychotics without first ruling out medical causes like pain, infection, constipation, or dehydration.

  • Do NOT use antipsychotics for wandering, sleep problems, or general restlessness—these are not psychosis and do not justify the risk.

  • Do NOT stop an antipsychotic abruptly; sudden withdrawal can cause rebound agitation. Use a slow taper over weeks.

  • Do NOT use haloperidol for routine agitation—it carries a high risk of movement side effects and worse outcomes; reserve it for extreme emergencies only.

  • Do NOT use benzodiazepines (such as lorazepam) for agitation except in a true emergency—they can cause confusion, falls, and paradoxical worsening.

  • Do NOT stack multiple sedating medications (antipsychotics, benzodiazepines, sleep aids) without careful review—combining them increases falls, confusion, and death.

Practical tools

  • PAINAD Scale (pain detection for nonverbal people)

    Score five items—breathing, vocalization, facial expression, body language, and consolability—each from 0 to 2. A total of 4 or higher suggests pain is likely, helping you tell pain-driven agitation apart from other behavioral causes when the person cannot describe how they feel.

  • Agitation/Behavior Log

    For each episode, record the date and time, the suspected trigger, the exact behavior, what you tried, and the outcome. Bring this to appointments—patterns often reveal a non-drug fix and give the clinician the evidence needed to make good decisions.

  • Medication Review Checklist & Full Medication List

    Keep a complete list of all prescriptions, over-the-counter drugs, and supplements. Ask the pharmacist or doctor to flag anticholinergic drugs (like Benadryl), high-dose antipsychotics or benzodiazepines, and anything causing drowsiness or falls that could be worsening behavior.

  • Lowest Dose, Shortest Time Contract

    If an antipsychotic is started, have the clinician write down the starting dose, the target symptom, the trial length, success criteria, the monitoring schedule, and a scheduled review/taper date. This prevents a medication from continuing indefinitely without re-evaluation and locks in the 2–8 month stability-then-reduce plan.

  • Acetaminophen pain-trial conversation

    Ask the doctor whether a short scheduled trial of acetaminophen (timing and dose to be set by the clinician based on liver function, alcohol use, and other medications) is safe—relieving unrecognized pain can sometimes calm agitation without any psychiatric drug.

  • Risk/benefit decision aid

    Use a structured decision aid with your clinician to weigh the specific benefits against the boxed-warning risks for your loved one's dementia type, age, and health, so the choice is shared and documented.

  • Facility behavior-plan request

    If your loved one lives in a nursing home or assisted living, request a copy of their 'Behavioral Management Plan' or 'antipsychotic reduction protocol,' and ask for a care-plan meeting with the medical director to confirm non-drug strategies were tried and a taper schedule is in place.

Treat new or sudden agitation as a medical red flag first—rule out a UTI, dehydration, or a new medication before assuming it's 'just the dementia.'

Antipsychotic benefit in dementia is modest and based on low-quality evidence, while the placebo effect in behavioral symptoms is real—another reason to optimize the environment and unmet needs before adding a drug.

Know which behaviors respond to antipsychotics (psychosis-linked aggression, dangerous delusions or hallucinations) versus which do not (wandering, restlessness, sleep problems) so you don't accept a high-risk drug for the wrong target.

Watch for extrapyramidal symptoms (stiffness, tremor, restlessness, abnormal movements) on antipsychotics—report them promptly, as they vary by drug.

Avoid anticholinergic drugs (like diphenhydramine/Benadryl and certain tricyclics such as amitriptyline) where possible—they worsen confusion and memory in older adults with dementia.

Ask about safer alternatives for related problems too, such as non-cognitive-impairing options for incontinence and whether long-term nightly sleep medication is truly warranted.

A 'therapeutic fiblet' (a gentle, reassuring redirection rather than confronting with reality) can defuse paranoia or distress without medication—ask your care team how to use it.

If a drug is started, document the plan and revisit guideline adherence: antipsychotics should be time-limited, monitored, and tapered—not left running indefinitely.

Caregiver well-being matters: spouse caregivers in particular are at risk for depression—seek support and your own clinical care so you can keep advocating effectively.

Discuss with your clinician

Bring your behavior log and full medication list, and ask: 'What is the specific FDA boxed warning about increased death and stroke for this drug, and how does it apply to my loved one's age, health, and dementia type—have you documented our risk/benefit discussion?' 'Can we try a non-drug behavior plan first, and have we addressed pain, infection, and constipation?' 'Is a scheduled acetaminophen trial safe given liver function, alcohol use, and other meds—what dose and schedule?' 'Are there safer non-antipsychotic options for this behavior, like citalopram, sertraline, donepezil, or memantine?' 'If we start one, is this the lowest effective dose, what side effects will we monitor and how often, and what specific behaviors tell us it's helping?' 'What happens if it isn't working after about 4 weeks?' 'When will we attempt a gradual dose reduction—can we set a target date now, after 2–8 months of stability?' and 'Can we consult a geriatric psychiatrist or behavioral neurologist for a second opinion?'

Related guides

Sources